Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using <sup>10</sup>B-p-Boronophenylalanine (BPA) with Special Reference to the Radiobiological Basis and Clinical Results

Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using <sup>10</sup>B-p-Boronophenylalanine (BPA) with Special Reference to the Radiobiological Basis and Clinical Results

BNCT is a radiotherapeutic method for cancer treatment that uses tumor-targeting <sup>10</sup>B-compounds. BNCT for cutaneous melanoma using BPA, a phenylalanine derivative, was first initiated by Mishima et al. in 1987. This article reviews the radiobiological basis of melanoma control...

Full description

Bibliographic Details
Main Author: Hiroshi Fukuda
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Cells
Subjects:
radiobiology
BNCT
BPA
melanoma
clinical outcome
Online Access:https://www.mdpi.com/2073-4409/10/11/2881

Similar Items

Similar Items